Wall Street analysts expect that Molecular Templates, Inc. (NASDAQ:MTEM – Get Rating) will report $6.38 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Molecular Templates’ earnings. The lowest sales estimate is $4.00 million and the highest is $8.75 million. Molecular Templates posted sales of $15.13 million […]
Brokerages predict that Molecular Templates, Inc. (NASDAQ:MTEM – Get Rating) will announce sales of $6.88 million for the current quarter, Zacks reports. Two analysts have issued estimates for Molecular Templates’ earnings, with the highest sales estimate coming in at $8.75 million and the lowest estimate coming in at $5.00 million. Molecular Templates posted sales of […]
Wall Street analysts predict that Molecular Templates, Inc. (NASDAQ:MTEM – Get Rating) will post ($0.42) earnings per share (EPS) for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Molecular Templates’ earnings, with estimates ranging from ($0.51) to ($0.30). Molecular Templates posted earnings per share of ($0.51) during the same quarter […]
Molecular Templates (NASDAQ:MTEM – Get Rating) had its price target cut by Barclays from $8.00 to $4.50 in a research note published on Wednesday morning, The Fly reports. They currently have an overweight rating on the biotechnology company’s stock. Separately, Zacks Investment Research upgraded shares of Molecular Templates from a sell rating to a hold […]
Wall Street analysts expect Molecular Templates, Inc. (NASDAQ:MTEM – Get Rating) to post $21.95 million in sales for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Molecular Templates’ earnings, with the lowest sales estimate coming in at $5.00 million and the highest estimate coming in at $37.50 million. Molecular Templates […]